Search Results 171-180 of 16097 for Conduction

1. A Study to Evaluate AZD1775 in Women with Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma - Mayo Clinic

   - Conduction abnormality not controlled with pacemaker or medication - Significant ventricular or supraventricular arrhythmias 7. History of Torsades de ...

2. High Resolution Gastric Mapping and Gastroduodenal Manometry - Mayo Clinic

   Known cardiac arrhythmia or major ECG abnormalities, i.e. cardiac conduction disturbances (2nd or 3rd degree AV block, prolonged QTc interval (> 460 msec) or ...

3. Arthritis - Doctors and departments - Mayo Clinic

   ... conduction study, Injection, Osteoarthritis, Back pain, Cervical myelopathy, Neck pain, Brachial plexus injury, Herniated disk, Arthritis, Bursitis ...

4. Ablation therapy - Doctors & Departments - Mayo Clinic

   ... Conduction system disease. Show more areas of focus for Anca Chiriac, M.D., Ph.D. Ryan S. D'Souza, M.D.. Anesthesiologist. Rochester, MN ...

5. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

   ... conduction abnormality, or clinically significant valvular disease - High-risk uncontrolled arrhythmias: i.e., atrial tachycardia with a heart rate > 100 ...

6. Stereotactic radiosurgery - Mayo Clinic

   Stereotactic radiosurgery (SRS) uses radiation beams to treat tumors in all parts of the body. Learn what to expect before, during and after this ...

7. A Study To Assess The Anti-fatigability Effect Of CK-2127107 In Elderly Male And Female Subjects With Limitations In Mobility - Mayo Clinic

   ... conduction block > first degree, or acute myocardial ischemic condition suspected on the Electrocardiogram (ECG) at screening (e.g., ST-segment elevation ...

8. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   Symptomatic congestive heart failure (i.e., Grade 2 or higher), history or current evidence of clinically significant cardiac arrhythmia and/or conduction ...

9. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

   ... conduction abnormalities. Clinically significant cardiac history or presence of ECG findings as judged by the Investigator or qualified designee at ...

10. Heart arrhythmia - Symptoms and causes - Mayo Clinic

    Conduction block. A block of the heart's electrical pathways can cause the signals that trigger the heartbeats to slow down or stop. Some blocks may cause ...